Tenaya Therapeutics, Inc. (TNYA)
0.6902
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 12:04
Tenaya Therapeutics Total Return Price : 0.6902 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 27, 2026 | 0.6952 |
| August 26, 2026 | 0.6962 |
| August 25, 2026 | 0.7014 |
| August 24, 2026 | 0.6747 |
| August 21, 2026 | 0.6973 |
| August 20, 2026 | 0.6905 |
| August 19, 2026 | 0.7129 |
| August 18, 2026 | 0.6985 |
| August 17, 2026 | 0.7001 |
| August 14, 2026 | 0.7281 |
| August 13, 2026 | 0.733 |
| August 12, 2026 | 0.7635 |
| August 11, 2026 | 0.7513 |
| August 10, 2026 | 0.7374 |
| August 07, 2026 | 0.7268 |
| August 06, 2026 | 0.7258 |
| August 05, 2026 | 0.7847 |
| August 04, 2026 | 0.7416 |
| August 03, 2026 | 0.729 |
| July 31, 2026 | 0.7403 |
| July 30, 2026 | 0.75 |
| July 29, 2026 | 0.7351 |
| July 28, 2026 | 0.7561 |
| July 27, 2026 | 0.7696 |
| July 24, 2026 | 0.775 |
| Date | Value |
|---|---|
| July 23, 2026 | 0.7731 |
| July 22, 2026 | 0.789 |
| July 21, 2026 | 0.8246 |
| July 20, 2026 | 0.8182 |
| July 17, 2026 | 0.817 |
| July 16, 2026 | 0.8376 |
| July 15, 2026 | 0.8432 |
| July 14, 2026 | 0.8646 |
| July 13, 2026 | 0.8365 |
| July 10, 2026 | 0.8704 |
| July 09, 2026 | 0.85 |
| July 08, 2026 | 0.8799 |
| July 07, 2026 | 0.92 |
| July 06, 2026 | 0.8654 |
| July 02, 2026 | 0.7869 |
| July 01, 2026 | 0.7459 |
| June 30, 2026 | 0.7391 |
| June 29, 2026 | 0.7349 |
| June 26, 2026 | 0.7175 |
| June 25, 2026 | 0.71 |
| June 24, 2026 | 0.7309 |
| June 23, 2026 | 0.726 |
| June 22, 2026 | 0.70 |
| June 18, 2026 | 0.7306 |
| June 17, 2026 | 0.7115 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Intellia Therapeutics, Inc. | 12.87 |
| Anavex Life Sciences Corp. | 2.99 |
| Arrowhead Pharmaceuticals, Inc. | 84.54 |
| Oncolytics Biotech, Inc. | 0.835 |
| Sangamo Therapeutics, Inc. | 0.1534 |